Combination Therapy for Multidrug-Resistant Klebsiella Pneumoniae Urinary Tract Infection

Hospital-acquired multidrug-resistant (MDR) Klebsiella infection is posing a significant challenge to physicians all around the world. The spread of multiple antibiotic resistance among various members of bacteria continues to be a significant clinical threat. Antibiotic susceptibility testing is th...

Descripción completa

Detalles Bibliográficos
Autores principales: Yasin, Faizan, Assad, Salman, Talpur, Abdul Subhan, Zahid, Mehr, Malik, Shuja A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2017
Materias:
Orthopedics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5608481/
https://www.ncbi.nlm.nih.gov/pubmed/28948123
http://dx.doi.org/10.7759/cureus.1503
Descripción
Sumario:Hospital-acquired multidrug-resistant (MDR) Klebsiella infection is posing a significant challenge to physicians all around the world. The spread of multiple antibiotic resistance among various members of bacteria continues to be a significant clinical threat. Antibiotic susceptibility testing is the initial step in optimizing the appropriate antibiotic therapy for infections with MDR Klebsiella. We report a case of MDR Klebsiella urinary tract infection (UTI) in a patient following a trimalleolar fracture, which was appropriately treated with a combination of amikacin and meropenem.

Ejemplares similares